[HTML][HTML] Post-stroke cognitive impairment: epidemiology, mechanisms and management

JH Sun, L Tan, JT Yu - Annals of translational medicine, 2014 - ncbi.nlm.nih.gov
Post-stroke cognitive impairment occurs frequently in the patients with stroke. The
prevalence of post-stroke cognitive impairment ranges from 20% to 80%, which varies for …

Amyloid-beta: a crucial factor in Alzheimer's disease

S Sadigh-Eteghad, B Sabermarouf, A Majdi… - Medical principles and …, 2015 - karger.com
Alzheimer's disease (AD) is the most prevalent form of dementia which affects people older
than 60 years of age. In AD, the dysregulation of the amyloid-beta (Aβ) level leads to the …

[HTML][HTML] Passive immunotherapies targeting Aβ and tau in Alzheimer's disease

SS Plotkin, NR Cashman - Neurobiology of disease, 2020 - Elsevier
Amyloid-β (Aβ) and tau proteins currently represent the two most promising targets to treat
Alzheimer's disease. The most extensively developed method to treat the pathologic forms of …

[PDF][PDF] Lipopolysaccharide-induced memory impairment in rats: a model of Alzheimer's disease.

R Zakaria, WMH Wan Yaacob, Z Othman… - Physiological …, 2017 - eprints.usm.my
Alzheimer's disease (AD) is a primary cause of dementia in the middle-aged and elderly
worldwide. Animal models for AD are widely used to study the disease mechanisms as well …

Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress

M Akbar, MM Essa, G Daradkeh, MA Abdelmegeed… - Brain research, 2016 - Elsevier
Mitochondria are important for providing cellular energy ATP through the oxidative
phosphorylation pathway. They are also critical in regulating many cellular functions …

Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort study

B Sabayan, LW Wijsman, JC Foster-Dingley, DJ Stott… - Bmj, 2013 - bmj.com
Objective To investigate the association between visit-to-visit variability in blood pressure
and cognitive function in old age (> 70 years). Design Prospective cohort study. Setting …

Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine

GC Mannino, F Andreozzi… - … /metabolism research and …, 2019 - Wiley Online Library
Type 2 diabetes mellitus (T2DM) is a chronic disease that has reached the levels of a global
epidemic. In order to achieve optimal glucose control, it is often necessary to rely on …

Selenium, selenoprotein P, and Alzheimer's disease: is there a link?

N Solovyev, E Drobyshev, G Bjørklund… - Free Radical Biology …, 2018 - Elsevier
The essential trace element, selenium (Se), is crucial to the brain but it may be potentially
neurotoxic, depending on dosage and speciation; Se has been discussed for decades in …

Animal models of Alzheimer disease: historical pitfalls and a path forward

SE Cavanaugh, JJ Pippin, ND Barnard - ALTEX-Alternatives to animal …, 2014 - altex.org
Alzheimer disease (AD) is a medically and financially overwhelming condition, and
incidence rates are expected to triple by 2050. Despite decades of research in animal …

[HTML][HTML] Copper, Iron, Selenium and lipo-glycemic dysmetabolism in Alzheimer's disease

J Aaseth, AV Skalny, PM Roos, J Alexander… - International Journal of …, 2021 - mdpi.com
The aim of the present review is to discuss traditional hypotheses on the etiopathogenesis of
Alzheimer's disease (AD), as well as the role of metabolic-syndrome-related mechanisms in …